￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
What is the latest price information for Acalabrutinib in 2025?

2026-02-01 22:25:32

Check Details
Ibrutinib/venetoclax produces long-term efficacy in Japanese R/R MCL trial

2026-02-01 22:25:32

Check Details
Latest Price Guide for Ruxolitinib Tablets/Ruxolitinib in 2025

2026-02-01 22:25:32

Check Details
Efficacy and patient feedback of dacomitinib/dacomitinib (Dozerun) tablets

2026-02-01 22:25:32

Check Details
What are the contraindications of Entrectinib/Luo Shengquan?

2026-02-01 22:25:32

Check Details
Duration of efficacy and metabolic characteristics of brigatinib/brigatinib (Embry)

2026-02-01 22:25:32

Check Details
What are the effective options for the combination of acotinib/cancostat?

2026-02-01 22:25:32

Check Details
Is ibrutinib/ibrutinib a domestic drug or an imported drug?

2026-02-01 22:25:32

Check Details
The efficacy of ruxolitinib tablets/Jiekewei in the treatment of myelofibrosis

2026-02-01 22:25:32

Check Details
Progress of phase III clinical research of ensifentrine-Ohtuvayre in COPD

2026-02-01 22:25:32

Check Details
Study on the resistance cycle of pyrotinib/erenib

2026-02-01 22:25:32

Check Details
Fulvestrant market price forecast and analysis in 2025

2026-02-01 22:25:32

Check Details
Category
相关知识